⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYMR News
Kymera Therapeutics, Inc. Common Stock
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
globenewswire.com
KYMR
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
globenewswire.com
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
globenewswire.com
KYMR
Kymera International Appoints Willson Ropp as Chief Executive Officer
prnewswire.com
KYMR
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
globenewswire.com
KYMR
Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm
prnewswire.com
KYMR
Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm
globenewswire.com
KYMR